| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/2003 | US6518435 Production method, a method of producing a compound represented by the formula (III) production method of oxyimino- alkanoic acid derivatives having an anti-diabetic activity. |
| 02/11/2003 | US6518432 The invention relates to a novel process for the preparation of certain pharmaceutically active pyridyl compounds. NMDA receptor antagonist activity. The compound known as (S)-1-phenyl-2-(2- pyridyl)ethanamine is of particular |
| 02/11/2003 | US6518429 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus |
| 02/11/2003 | US6518428 The present invention relates to the area of platinum drugs. In particular, it relates to an improved process for preparing platinum complexes having the general formula (Ia) or (Ib): as defined of herein, |
| 02/11/2003 | US6518427 Compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of these compounds. They are also rapidly converted back to the parent amines in vivo, making them useful as prodrugs of the parent amines. |
| 02/11/2003 | US6518425 A process for producing a 1,3-oxathiolane nucleoside comprising reacting a 5-halo-2-protected-oxymethyl-1,3-oxathiolane with a silylated purine or pyrimidine without the addition of a Lewis acid or an additional base to the reaction |
| 02/11/2003 | US6518422 Hydrogenation of 5,5-dioxo-2,3-dihydro-1H-pyrrolo-(2,1-c)(1,2,4)benzothiadiazine with a complex of ruthenium dichloride with 2,2'-bis(diphenylphosphine)-1,1'-binaphthyl and 1,2-diphenylethylenediamine as catalyst |
| 02/11/2003 | US6518421 Process for the preparation of epothilone analogs |
| 02/11/2003 | US6518413 Isolated nucleic acid encoding the polypeptide which, on expression in a host cell, produces the polypeptide; use in treatment of muscular dystrophy |
| 02/11/2003 | US6518410 Immunosuppressive agent, anticancer agent and DNA polymerase alpha inhibitor. |
| 02/11/2003 | US6518319 Method of preparing and using compositions extracted from vegetable matter for the treatment of female symptoms |
| 02/11/2003 | US6518318 Stimulating transport of glucose into animal tissue by the administration of pinitol |
| 02/11/2003 | US6518317 Antiviral agents |
| 02/11/2003 | US6518316 Cytokine production and tyrosine kinase inhibitors |
| 02/11/2003 | US6518314 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions |
| 02/11/2003 | US6518312 Activator protein (AP); treating diseases associated with immune suppressive states; benzmides such as N-((2-Diethylamino)propyl)-4-isobutyrylamino-2-methoxy-benzamide |
| 02/11/2003 | US6518311 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518308 Administering to the patient who will undergo surgical procedure a halogenated organic compound to prevent or retard the development of surgical adhesions |
| 02/11/2003 | US6518307 Orally administering an effective amount of a peracid to an animal. |
| 02/11/2003 | US6518306 PDE4 inhibitors particularly in regards to treating allergic and inflammatory diseases |
| 02/11/2003 | US6518305 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| 02/11/2003 | US6518304 Fungicidal composition |
| 02/11/2003 | US6518303 Selectively inhibit COX-2 in preference to COX-1 and are useful in the treatment of COX-2 mediated diseases, such as inflammation, pain, fever and asthma with fewer side effects |
| 02/11/2003 | US6518301 Better selectivity than estrogen for the estrogen receptor-beta over receptor-alpha; treatment of Alzheimer's disease, anxiety, depression, osteoporosis, cardiovascular disease, rheumatoid arthritis, or prostate cancer |
| 02/11/2003 | US6518300 Antiplipemic agent, anticholesterol agents |
| 02/11/2003 | US6518298 Methods and compositions for inhibition of angiogenesis with EM-138 |
| 02/11/2003 | US6518297 Selective 5-HT6 receptor ligands |
| 02/11/2003 | US6518295 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance P |
| 02/11/2003 | US6518294 Fused pyrazolyl compounds |
| 02/11/2003 | US6518293 Anti-HIV imidazolone derivatives |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518291 Inosine-5'-monophosphate dehydrogenase inhibitors |
| 02/11/2003 | US6518290 Substituted oxazoles and thiazoles derivatives as HPPAr alpha activators |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/11/2003 | US6518288 Amlodipine fumarate |
| 02/11/2003 | US6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518285 Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518282 4-Arylpiperidine derivatives for the treatment of pruritus |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | US6518278 Administering a synergistically effective amount of irinotecane and subsequently with a synergistically effective amount of cis-oxalato (1R,2R-diaminocyclohexane) Pt (II) |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518274 Use of cyclopentabenzofuran-derivatives for combating (NF-κB)-dependent diseases |
| 02/11/2003 | US6518270 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof |
| 02/11/2003 | US6518269 Cancer treatment |
| 02/11/2003 | US6518268 Telomerase inhibitors and methods of their use |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518265 1H-imidazopyridine derivatives |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | US6518263 Imidazo[4,5-b]pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum |
| 02/11/2003 | US6518262 22R-hydroxycholesta-8, 14-diene derivatives for the inhibition of meiosis |
| 02/11/2003 | US6518261 Prostate cancer |
| 02/11/2003 | US6518260 (α-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof |
| 02/11/2003 | US6518259 Compositions for treating autoimmune disease |
| 02/11/2003 | US6518258 6-sulphamoyl -3-quinolyphosphonic acid compounds |
| 02/11/2003 | US6518253 Treatment of viral infections using the L-isomer of ribavirin |
| 02/11/2003 | US6518252 Method of treating aquatic animals with an antimicrobial agent and chelating agent |
| 02/11/2003 | US6518251 Macrolides |
| 02/11/2003 | US6518250 Agent for preventing and curing hindrance of ischemic reperfusion |
| 02/11/2003 | US6518249 Oligosaccharide derivatives and process for producing the same |
| 02/11/2003 | US6518248 Method of treating gastric or colon cancer by administration of a sulfoquinovosylacylglycerol ester |
| 02/11/2003 | US6518247 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 02/11/2003 | US6518246 Pharmaceutical composition and method for the treatment of neoplastic cells |
| 02/11/2003 | US6518245 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
| 02/11/2003 | US6518244 Cardiovascular disorders |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6518066 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
| 02/11/2003 | US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor |
| 02/11/2003 | US6518062 Enzyme combinations for destroying proliferative cells |
| 02/11/2003 | US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells |
| 02/11/2003 | US6518031 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/11/2003 | US6517883 Satiety product |
| 02/11/2003 | US6517871 Amorphous ammonium salt; blocking angiotensin II receptors; treating hypertension, congestive heart failure and renal failure |
| 02/11/2003 | US6517870 Improved taste by reducing bitterness and saltiness |
| 02/11/2003 | US6517867 Dry mix formulation for bisphosphonic acids |
| 02/11/2003 | US6517866 Sertraline salts and sustained-release dosage forms of sertraline |
| 02/11/2003 | US6517864 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 02/11/2003 | US6517859 Injectable, drug delivery vehicles; controlled release of bioactive agents to sites within the central nervous system; dopamine, cholecystokinin, and epidermal and basic fibroblast growth factors for Parkinson's disease |
| 02/11/2003 | US6517858 Bioactive prostheses with immunosuppressive, antistenotic and antithrombotic properties |
| 02/11/2003 | US6517855 Method of sterilizing |
| 02/11/2003 | US6517854 Antimicrobial sanitizing lotion with skin protection properties |
| 02/11/2003 | US6517849 Tissue products containing antiviral agents which are mild to the skin |
| 02/11/2003 | US6517848 Method for sequestration of skin irritants with absorbent article composition |
| 02/11/2003 | US6517847 Topical gel delivery system |
| 02/11/2003 | US6517846 N-long chain acyl-asparagine or glutamine; effects suitable for sensitive skin, dry skin, roughening skin or skin with atopic dermatitis |
| 02/11/2003 | US6517841 Solid compositions and liquid preparations for oral administration which contain cocoa polyphenols |
| 02/11/2003 | US6517836 Aziridin-1-yl nitrobenzamides as prodrugs in conjunction with nitroreductase enzymes |
| 02/11/2003 | US6517827 Anionic polymers as toxin binders and antibacterial agent |
| 02/11/2003 | US6517826 Anionic polymers as toxin binders and antibacterial agents |
| 02/11/2003 | US6517825 Polyether-based bile acid sequestrants |
| 02/11/2003 | US6517822 Formulations and methods for straightening hair |
| 02/11/2003 | US6517812 D1-like agonists or antagonists; SCH 23390 |
| 02/11/2003 | US6517811 Compounds for cancer imaging and therapy |
| 02/11/2003 | US6517810 Palliation of bone pain due to cancer by the administration of a tin stannic (Sn+4) chelate complex |
| 02/11/2003 | US6517809 Using a breath test; vehicle containing a sugar is powder or granules, coating vehicle with an isotope-labeled urea and encapsulating the coated vehicle in gelatin |
| 02/11/2003 | US6517742 2-(butyl 4'-ylaminobenzoate)-4,6-bis((1,3,3,3-tetramethyl-1 -((trimethylsilyl)oxy)disiloxanyl)propyl-3-ylamino)-s-triazine; s-triazine derivatives substituted by at least one silicone group; from cyanuric chloride |
| 02/11/2003 | CA2320129C Suspension aerosol formulations |
| 02/11/2003 | CA2222361C Hydroxypropylated quaternary ammonium derivatives having an ester function, and cosmetic or dermatological compositions containing them |